PA
PBPH

Parallel Advisors’s Portfolio Building Block World Pharma and Biotech Index ETF PBPH Stock Holding History

Parallel Advisors’s Portfolio PBPH Stock Details PBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28
Closed -$716 – 4103
2026
Q1 		$716 Buy
+28
New +$729 ﹤0.01% 3604

Other funds holding PBPH

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parallel Advisors's PBPH Position: Q2 2026 in Review

Parallel Advisors sold out of Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) in Q2 2026, closing a stake of 28 shares — an estimated $716 sold.

Parallel Advisors first reported a position in PBPH in Q1 2026 and held it in 1 quarter. The position peaked at $716 in Q1 2026. 9 funds tracked by Wall St. Rank hold PBPH as of Q2 2026.

  • Parallel Advisors reported no remaining Portfolio Building Block World Pharma and Biotech Index ETF position as of Q2 2026 after selling out during the quarter.
  • Parallel Advisors sold 28 Portfolio Building Block World Pharma and Biotech Index ETF shares in Q2 2026, an estimated $716.
  • Parallel Advisors first reported a position in Portfolio Building Block World Pharma and Biotech Index ETF in Q1 2026 and held it in 1 quarter.
  • Parallel Advisors's Portfolio Building Block World Pharma and Biotech Index ETF position peaked at $716 in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Portfolio Building Block World Pharma and Biotech Index ETF as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.